Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Vaccine ; 2024 Jan 17.
Article in English | MEDLINE | ID: mdl-38238113

ABSTRACT

During the COVID-19 vaccination rollout from March 2021- December 2022, the Centers for Disease Control and Prevention funded 110 primary and 1051 subrecipient partners at the national, state, local, and community-based level to improve COVID-19 vaccination access, confidence, demand, delivery, and equity in the United States. The partners implemented evidence-based strategies among racial and ethnic minority populations, rural populations, older adults, people with disabilities, people with chronic illness, people experiencing homelessness, and other groups disproportionately impacted by COVID-19. CDC also expanded existing partnerships with healthcare professional societies and other core public health partners, as well as developed innovative partnerships with organizations new to vaccination, including museums and libraries. Partners brought COVID-19 vaccine education into farm fields, local fairs, churches, community centers, barber and beauty shops, and, when possible, partnered with local healthcare providers to administer COVID-19 vaccines. Inclusive, hyper-localized outreach through partnerships with community-based organizations, faith-based organizations, vaccination providers, and local health departments was critical to increasing COVID-19 vaccine access and building a broad network of trusted messengers that promoted vaccine confidence. Data from monthly and quarterly REDCap reports and monthly partner calls showed that through these partnerships, more than 295,000 community-level spokespersons were trained as trusted messengers and more than 2.1 million COVID-19 vaccinations were administered at new or existing vaccination sites. More than 535,035 healthcare personnel were reached through outreach strategies. Quality improvement interventions were implemented in healthcare systems, long-term care settings, and community health centers resulting in changes to the clinical workflow to incorporate COVID-19 vaccine assessments, recommendations, and administration or referrals into routine office visits. Funded partners' activities improved COVID-19 vaccine access and addressed community concerns among racial and ethnic minority groups, as well as among people with barriers to vaccination due to chronic illness or disability, older age, lower income, or other factors.

2.
Nat Food ; 2(12): 935-943, 2021 12.
Article in English | MEDLINE | ID: mdl-37118255

ABSTRACT

Slow growth in the bivalve mariculture sector results from production inefficiencies, food safety concerns, limited availability of convenience products and low consumer demand. Here we assess whether bivalves could meet mass-market seafood demand across the bivalve value chain. We explore how bivalve production could become more efficient, strategies for increasing edible meat yield and how food safety could be improved through food processing technologies and new depuration innovations. Finally, we examine barriers to consumer uptake, such as food allergen prevalence and bivalve preparation challenges, highlighting that appealing and convenient bivalve food products could provide consumers with nutritious and sustainable seafood options-and contribute positively to global food systems.

3.
Eur J Gastroenterol Hepatol ; 21(1): 9-17, 2009 Jan.
Article in English | MEDLINE | ID: mdl-19011577

ABSTRACT

Restorative procto-colectomy with ileal pouch anal anastomosis has become the most common elective surgical procedure for patients with ulcerative colitis and is becoming popular in those with familial adenomatous polyposis coli. The procedure itself is primarily carried out in specialist surgical centres but an increasing number are being performed and followed up in district general hospitals. These patients are now filtering through general surgical and gastroenterology clinics and are frequently seen in primary care. Pouchitis, an inflammatory condition of the ileal pouch, has become the third most important form of inflammatory bowel disease. As research develops in this area, other complications are being found. The aim of this review is to provide an up-to-date, evidence-based approach to the clinical management of these patients.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Colonic Pouches , Postoperative Complications/drug therapy , Pouchitis/drug therapy , Proctocolectomy, Restorative , Adenomatous Polyposis Coli/surgery , Ambulatory Care , Bone Diseases, Metabolic/etiology , Colitis, Ulcerative/surgery , Female , Humans , Malabsorption Syndromes/etiology , Male , Postoperative Care/methods , Postoperative Complications/etiology , Pouchitis/etiology , Recurrence , Sexual Dysfunction, Physiological/etiology
SELECTION OF CITATIONS
SEARCH DETAIL